
Eptifibatide acetate
CAS No. 881997-86-0
Eptifibatide acetate( —— )
Catalog No. M19934 CAS No. 881997-86-0
Eptifibatide an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 45 | Get Quote |
![]() ![]() |
10MG | 50 | Get Quote |
![]() ![]() |
25MG | 81 | Get Quote |
![]() ![]() |
50MG | 130 | Get Quote |
![]() ![]() |
100MG | 203 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEptifibatide acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEptifibatide an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue.
-
DescriptionEptifibatide an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCardiovascular Disease
-
IndicationStroke
Chemical Information
-
CAS Number881997-86-0
-
Formula Weight——
-
Molecular FormulaC35H49N11O9S2·xC2H4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC(=O)O.NC(=O)[C@@H]3CSSCCC(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2cnc1ccccc12)C(=O)N4CCC[C@H]4C(=O)N3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Amoroso G. et al. Eptifibatide and abciximab exhibit equivalent antiplatelet efficacy in an experimental model of stenting in both healthy volunteers and patients with coronary artery disease. J Cardiovasc Pharmacol 2001. 38(4): p. 633-41.
molnova catalog



related products
-
CGP 35348
CGP 35348 is a selective antagonist of GABAB receptor (EC50 = 34 μM). CGP 35348 can be used in studies of neuromuscular coordination and spatial learning after neonatal brain damage in albino mice.
-
Moracin M
Moracin M, a phenolic component in the skin of Morus alba Linn., is a potent phosphodiesterase-4 (PDE4) inhibitor with IC50 values of 2.9, 4.5, >40, and >100 μM for PDE4D2, PDE4B2, PDE5A1, and PDE9A2, respectively. Moracin M has anti-inflammatory activity.
-
Inotuzumab
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22.